Bioequivalence of a Zanubrutinib Tablet Compared to Capsules in Healthy Adult Participants

ClinicalTrials.gov ID: NCT05767398

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05767398. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 9:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single-dose, Open-label, Randomized, Replicate Crossover Study in Healthy Adult Subjects to Assess the Bioequivalence of a Zanubrutinib Tablet Compared to Zanubrutinib Capsules

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study to determine the bioequivalence of a zanubrutinib tablet compared to capsules in healthy adult participants.

Study identification

NCT ID: NCT05767398
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: BeiGene; Industry
Enrollment: 58 participants

Conditions and interventions

Conditions

Healthy Volunteers

Interventions

Zanubrutinib Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 7, 2023 (Actual)
Primary completion: Apr 28, 2023 (Actual)
Completion: Apr 28, 2023 (Actual)
Last update posted: Oct 26, 2024

2023

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Fortrea Clinical Research Unit	Dallas	Texas	75247	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05767398, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 26, 2024 · Synced Nov 12, 2026